Mast cells and inflammatory bowel disease

Current Opinion in Pharmacology

Volumn 25, Issue , 2015, Pages 45-49

  Boeckxstaens, Guy ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; ADENOSINE TRIPHOSPHATE; CHYMASE; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; DOCUSATE SODIUM; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 1BETA; LEUKOCYTE MONOIMMUNOGLOBULIN LIKE RECEPTOR 3; MONOCYTE CHEMOTACTIC PROTEIN; PROTEINASE ACTIVATED RECEPTOR; PURINERGIC P2X7 RECEPTOR; TRYPTASE; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; LMBR1L PROTEIN, HUMAN; PROTEINASE INHIBITOR;

ACUTE DISEASE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; COLITIS; CONNECTIVE TISSUE MAST CELL; CROHN DISEASE; CROSS LINKING; DELAYED HYPERSENSITIVITY; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINAL FIBROSIS; LAMINA PROPRIA; MAST CELL; MUCOSAL IMMUNITY; MUCOSAL MAST CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRESS; SUBMUCOSA; ULCERATIVE COLITIS; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; ENZYMOLOGY; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; METABOLISM; MOLECULARLY TARGETED THERAPY; PROCEDURES; SECRETION (PROCESS);

ANIMALS; HUMANS; INFLAMMATORY BOWEL DISEASES; MAST CELLS; MODELS, BIOLOGICAL; MOLECULAR TARGETED THERAPY; PROTEASE INHIBITORS; RECEPTORS, CELL SURFACE;

EID: 84948462870     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2015.11.005     Document Type: Review

References (34)

1. D.C. Baumgart, and W.J. Sandborn Crohn's disease Lancet 380 2012 1590 1605
2. I. Ordas, L. Eckmann, M. Talamini, D.C. Baumgart, and W.J. Sandborn Ulcerative colitis Lancet 380 2012 1606 1619
3. S.N. Abraham, and A.L. St John Mast cell-orchestrated immunity to pathogens Nat Rev Immunol 10 2010 440 452
4. B.A. Sayed, and M.A. Brown Mast cells as modulators of T-cell responses Immunol Rev 217 2007 53 64
5. S.C. Bischoff Physiological and pathophysiological functions of intestinal mast cells Semin Immunopathol 31 2009 185 205
6. L.L. Reber, R. Sibilano, K. Mukai, and S.J. Galli Potential effector and immunoregulatory functions of mast cells in mucosal immunity Mucosal Immunol 8 2015 444 463
7. L.E. Cheng, K. Hartmann, A. Roers, M.F. Krummel, and R.M. Locksley Perivascular mast cells dynamically probe cutaneous blood vessels to capture immunoglobulin E Immunity 38 2013 166 175
8. M.F. Gurish, and K.F. Austen Developmental origin and functional specialization of mast cell subsets Immunity 37 2012 25 33
9. N. Weidner, and K.F. Austen Heterogeneity of mast cells at multiple body sites. Fluorescent determination of avidin binding and immunofluorescent determination of chymase, tryptase, and carboxypeptidase content Pathol Res Pract 189 1993 156 162
10. A.M. Gilfillan, and C. Tkaczyk Integrated signalling pathways for mast-cell activation Nat Rev Immunol 6 2006 218 230
11. S.C. Bischoff, and S. Kramer Human mast cells, bacteria, and intestinal immunity Immunol Rev 217 2007 329 337
12. C.M. Gelbmann, S. Mestermann, V. Gross, M. Kollinger, J. Scholmerich, and W. Falk Strictures in Crohn's disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin Gut 45 1999 210 217
13. A. Andoh, Y. Deguchi, O. Inatomi, Y. Yagi, S. Bamba, T. Tsujikawa, and Y. Fujiyama Immunohistochemical study of chymase-positive mast cells in inflammatory bowel disease Oncol Rep 16 2006 103 107
14. M. Vivinus-Nebot, G. Frin-Mathy, H. Bzioueche, R. Dainese, G. Bernard, R. Anty, J. Filippi, M.C. Saint-Paul, M.K. Tulic, V. Verhasselt, and et al. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation Gut 63 2014 744 752
15. Y. Kurashima, T. Amiya, T. Nochi, K. Fujisawa, T. Haraguchi, H. Iba, H. Tsutsui, S. Sato, S. Nakajima, H. Iijima, and et al. Extracellulat ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors Nat Commun 3 2012 1034
16. M. Raithel, H.T. Schneider, and E.G. Hahn Effect of substance P on histamine secretion from gut mucosa in inflammatory bowel disease Scand J Gastroenterol 34 1999 496 503
17. M. Raithel, S. Winterkamp, A. Pacurar, P. Ulrich, J. Hochberger, and E.G. Hahn Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease Scand J Gastroenterol 36 2001 174 179
18. S. Winterkamp, M. Weidenhiller, P. Otte, J. Stolper, D. Schwab, E.G. Hahn, and M. Raithel Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease Am J Gastroenterol 97 2002 3071 3077
19. A.A. te Velde, F. de Kort, E. Sterrenburg, I. Pronk, F.J. ten Kate, D.W. Hommes, and S.J. van Deventer Comparative analysis of colonic gene expression of three experimental colitis models mimicking inflammatory bowel disease Inflamm Bowel Dis 13 2007 325 330
20. A. Rijnierse, F.P. Nijkamp, and A.D. Kraneveld Mast cells and nerves tickle in the tummy: implications for inflammatory bowel disease and irritable bowel syndrome Pharmacol Ther 116 2007 207 235
21. T. Matsukawa, K. Izawa, M. Isobe, M. Takahashi, A. Maehara, Y. Yamanishi, A. Kaitani, K. Okumura, T. Teshima, T. Kitamura, and et al. Ceramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activation Gut 2015
22. C. Nakahashi-Oda, S. Tahara-Hanaoka, M. Shoji, Y. Okoshi, T. Nakano-Yokomizo, N. Ohkohchi, T. Yasui, H. Kikutani, S. Honda, K. Shibuya, and et al. Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor J Exp Med 209 2012 1493 1503
23. N. Vergnolle Protease inhibition as new therapeutic strategy for GI disease Gut 2015 in press
24. N. Vergnolle, L. Cellars, A. Mencarelli, G. Rizzo, S. Swaminathan, P. Beck, M. Steinhoff, P. Andrade-Gordon, N.W. Bunnett, M.D. Hollenberg, and et al. A role for proteinase-activated receptor-1 in inflammatory bowel diseases J Clin Invest 114 2004 1444 1456
25. M.J. Hamilton, M.J. Sinnamon, G.D. Lyng, J.N. Glickman, X. Wang, W. Xing, S.A. Krilis, R.S. Blumberg, R. Adachi, D.M. Lee, and et al. Essential role for mast cell tryptase in acute experimental colitis Proc Natl Acad Sci U S A 108 2011 290 295
26. P.M. Hansbro, M.J. Hamilton, M. Fricker, S.L. Gellatly, A.G. Jarnicki, D. Zheng, S.M. Frei, G.W. Wong, S. Hamadi, S. Zhou, and et al. Importance of mast cell Prss31/transmembrane tryptase/tryptase-gamma in lung function and experimental chronic obstructive pulmonary disease and colitis J Biol Chem 289 2014 18214 18227
27. J.C. Hoving, F. Kirstein, N.E. Nieuwenhuizen, L.C. Fick, E. Hobeika, M. Reth, and F. Brombacher B cells that produce immunoglobulin E mediate colitis in BALB/c mice Gastroenterology 142 2012 96 108
28. A. Rijnierse, F.A. Redegeld, B.R. Blokhuis, M.W. Van der Heijden, A.A. Te Velde, I. Pronk, D.W. Hommes, F.P. Nijkamp, A.S. Koster, and A.D. Kraneveld Ig-free light chains play a crucial role in murine mast cell-dependent colitis and are associated with human inflammatory bowel diseases J Immunol 185 2010 653 659
29. C.N. Bernstein, S. Singh, L.A. Graff, J.R. Walker, N. Miller, and M. Cheang A prospective population-based study of triggers of symptomatic flares in IBD Am J Gastroenterol 105 2010 1994 2002
30. J.D. Soderholm, and M.H. Perdue Stress and gastrointestinal tract. II. Stress and intestinal barrier function Am J Physiol Gastrointest Liver Physiol 280 2001 G7 G13
31. C. Wallon, M. Persborn, M. Jonsson, A. Wang, V. Phan, M. Lampinen, M. Vicario, J. Santos, P.M. Sherman, M. Carlson, and et al. Eosinophils express muscarinic receptors and corticotropin-releasing factor to disrupt the mucosal barrier in ulcerative colitis Gastroenterology 140 2011 1597 1607
32. B.S. Qiu, B.A. Vallance, P.A. Blennerhassett, and S.M. Collins The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis Nat Med 5 1999 1178 1182
33. P.Y. Zheng, B.S. Feng, C. Oluwole, S. Struiksma, X. Chen, P. Li, S.G. Tang, and P.C. Yang Psychological stress induces eosinophils to produce corticotrophin releasing hormone in the intestine Gut 58 2009 1473 1479
34. W.J. Tremaine, A. Brzezinski, J.A. Katz, D.C. Wolf, T.J. Fleming, J. Mordenti, L.C. Strenkoski-Nix, M.C. Kurth, and A.U.C.S. Group Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot study Aliment Pharmacol Ther 16 2002 407 413